Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system? (Q57385748)

1

0 references

Anne Perrocheau

2

0 references

Esther Kissling

3

0 references

Daniel Levy Bruhl

4

0 references

James Stuart

6

0 references

Pawel Stefanoff

7

0 references

Sigrid Heuberger

8

0 references

Paula Kriz

9

0 references

Anne Vergison

10

0 references

Sabine C. de Greeff

11

0 references

Andrew Amato-Gauci

12

0 references

Lucia Pastore Celentano

Historical changes in pneumococcal serogroup distribution: implications for the era of pneumococcal conjugate vaccines.

13

0 references

language of work or name

English

0 references

publication date

May 2010

0 references

published in

Vaccine

0 references

volume

28

0 references

issue

23

0 references

page(s)

3920-3928

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Serotype replacement in invasive pneumococcal disease: where do we go from here?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Burden of paediatric invasive pneumococcal disease in Europe, 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Streptococcus pneumoniae in western Europe: serotype distribution and incidence in children less than 2 years old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Streptococcus pneumoniae incidence in western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Incidence of vaccine preventable pneumococcal invasive infections and blood culture practices in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Trends in incidence of pneumococcal disease before introduction of conjugate vaccine: South West England, 1996-2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Emergence of Invasive Pneumococcal Disease Caused by Nonvaccine Serotypes in the Era of 7-Valent Conjugate Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.069